SENORES PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of SENORES PHARMACEUTICALS have increased by 85.65% YoY .
The Earnings Per Share (EPS) of SENORES PHARMACEUTICALS has increased by 96.93 % YoY. |
||
SENORES PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 544319|NSE : SENORES]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹398 Cr | ₹215 Cr | ₹353 Cr | ₹14 Cr | ₹14 Cr |
| Expenses | ₹309 Cr | ₹173 Cr | ₹227 Cr | ₹12 Cr | ₹12 Cr |
| Operating Profit (Excl OI) | ₹90 Cr | ₹42 Cr | ₹127 Cr | ₹1.95 Cr | ₹1.95 Cr |
| Other Income | ₹19 Cr | ₹2.82 Cr | ₹37 Cr | ₹0.46 Cr | ₹0.46 Cr |
| Interest | ₹22 Cr | ₹9.45 Cr | ₹21 Cr | ₹0.57 Cr | ₹0.57 Cr |
| Depreciation | ₹17 Cr | ₹10.00 Cr | ₹18 Cr | ₹0.71 Cr | ₹0.71 Cr |
| Profit Before Tax | ₹71 Cr | ₹25 Cr | ₹124 Cr | ₹1.14 Cr | ₹1.14 Cr |
| Profit After Tax | ₹58 Cr | ₹33 Cr | ₹84 Cr | ₹0.99 Cr | ₹0.99 Cr |
| Consolidated Net Profit | ₹59 Cr | ₹31 Cr | ₹84 Cr | ₹0.99 Cr | ₹0.99 Cr |
| Earnings Per Share (Rs) | ₹25.05 | ₹12.72 | ₹10.31 | ₹8.59 | ₹1.13 |
| PAT Margin (%) | 19.21 | 14.65 | 15.25 | 23.86 | 6.99 |
| ROE(%) | 14.14 | 11.78 | 26.19 | 20.55 | 2.71 |
| ROCE(%) | 15.66 | 11.94 | 12.31 | 18.56 | 3.36 |
| Total Debt/Equity(x) | 0.35 | 0.39 | 1.22 | 1.34 | 0.39 |
Key Financials |
||
| Market Cap | : | ₹ 6,764.9 Cr |
| Revenue (TTM) | : | ₹ 691.7 Cr |
| Net Profit(TTM) | : | ₹ 130.8 Cr |
| EPS (TTM) | : | ₹ 28.4 |
| P/E (TTM) | : | 51.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SENORES PHARMACEUTICALS | -1.9% | -1.6% | 96.3% |
| SUN PHARMACEUTICAL INDUSTRIES | -3% | -5.2% | 17.9% |
| DIVIS LABORATORIES | 0.2% | 9.7% | 56.1% |
| TORRENT PHARMACEUTICALS | 1.3% | 2% | 36.5% |
| CIPLA | -2.2% | -6.6% | -10.5% |
| DR REDDYS LABORATORIES | 1.4% | -3.7% | -8.8% |
| MANKIND PHARMA | -1.9% | -5.8% | -12.9% |
| LUPIN | -0.4% | -7.3% | 6.6% |
| ZYDUS LIFESCIENCES | -3.1% | -4.6% | 10.8% |
SENORES PHARMACEUTICALS Revenues
[BOM: 544319|NSE : SENORES]
| Y-o-Y | 85.65 % |
| 5 Yr CAGR | 130.25 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹398 Cr | 85.65 | |
| Mar2025 | ₹215 Cr | -39.29 | |
| Mar2024 | ₹353 Cr | 2,393.79 | |
| Mar2023 | ₹14 Cr | 0.00 | |
| Mar2022 | ₹14 Cr | - | |
SENORES PHARMACEUTICALS Operating Profit
[BOM: 544319|NSE : SENORES]
| Y-o-Y | 115.78 % |
| 5 Yr CAGR | 160.36 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹90 Cr | 115.78 | |
| Mar2025 | ₹42 Cr | -67.19 | |
| Mar2024 | ₹127 Cr | 6,390.78 | |
| Mar2023 | ₹1.95 Cr | 0.00 | |
| Mar2022 | ₹1.95 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 16.20 % |
| 5 Yr CAGR | 13.07 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 22.52% | 16.20 | |
| Mar2025 | 19.38% | -45.94 | |
| Mar2024 | 35.85% | 160.16 | |
| Mar2023 | 13.78% | 0.00 | |
| Mar2022 | 13.78% | - | |
SENORES PHARMACEUTICALS Profit After Tax
[BOM: 544319|NSE : SENORES]
| Y-o-Y | 86.14 % |
| 5 Yr CAGR | 177.26 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹59 Cr | 86.14 | |
| Mar2025 | ₹31 Cr | -62.69 | |
| Mar2024 | ₹84 Cr | 8,409.59 | |
| Mar2023 | ₹0.99 Cr | 0.00 | |
| Mar2022 | ₹0.99 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 31.13 % |
| 5 Yr CAGR | 28.75 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 19.21 % | 31.13 | |
| Mar2025 | 14.65 % | -3.93 | |
| Mar2024 | 15.25 % | -36.09 | |
| Mar2023 | 23.86 % | 241.34 | |
| Mar2022 | 6.99 % | - | |
SENORES PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 544319|NSE : SENORES]
| Y-o-Y | 96.93 % |
| 5 Yr CAGR | 116.99 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹25 | 96.93 | |
| Mar2025 | ₹13 | 23.38 | |
| Mar2024 | ₹10 | 20.02 | |
| Mar2023 | ₹8.59 | 660.18 | |
| Mar2022 | ₹1.13 | - | |
SENORES PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 544319|NSE : SENORES]
| Y-o-Y | 31.16 % |
| 5 Yr CAGR | 46.93 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 15.66% | 31.16 | |
| Mar2025 | 11.94% | -3.01 | |
| Mar2024 | 12.31% | -33.67 | |
| Mar2023 | 18.56% | 452.38 | |
| Mar2022 | 3.36% | - | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹1,467.5 |
| Current MarketCap | : | ₹ 6,764.9 Cr |
| Updated EOD on | : | Sep 11,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | -1.9% |
-1.6% |
96.3% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
SENORES PHARMACEUTICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 0.6% | 0.5% | 15.8% |
You may also like the below Video Courses
FAQ about SENORES PHARMACEUTICALS Financials
How the annual revenues of SENORES PHARMACEUTICALS have changed ?
The Revenues of SENORES PHARMACEUTICALS have increased by 85.65% YoY .
How the Earnings per Share (EPS) of SENORES PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of SENORES PHARMACEUTICALS has increased by 96.93 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs